Diabetic Foot Files

Forgotten Infection Friday: Tranq Wounds- Xylazine Damage — When a Veterinary Sedative Destroys Human Tissue

16 min · 10 de jul de 2026
Portada del episodio Forgotten Infection Friday: Tranq Wounds- Xylazine Damage — When a Veterinary Sedative Destroys Human Tissue

Descripción

This episode explains how xylazine ("tranq"), a veterinary sedative now found in the illicit drug supply, is causing severe, fast-progressing wounds and infections when mixed with fentanyl. It reviews the drug's vasoconstrictive effects, wound features (necrosis, deep infection, slow healing), key differences from diabetic foot ulcers, treatment priorities (debridement, antibiotics, advanced wound care), and the need for compassionate, comprehensive care and referral for substance use disorders.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Diabetic Foot Files!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

339 episodios

episode LIMBWatch Series: Reinventing Hydrotherapy—Jason Ayer, RN’s Topical Oxygen-Powered Approach to Limb Salvage artwork

LIMBWatch Series: Reinventing Hydrotherapy—Jason Ayer, RN’s Topical Oxygen-Powered Approach to Limb Salvage

In this episode of Limb Watch Series with Diabetic Foot Files, host interviews Jason Ayers, a wound care RN and inventor of a topical oxygen hydrotherapy kit that combines warmed antimicrobial cleansing solution with localized oxygen bubbles to cleanse and promote healing in chronic wounds, especially diabetic foot ulcers. Jason explains the origin and prototype development, demonstrates a typical 10–15 minute treatment session, and shares case-study results showing faster cleansing, improved tissue color, reduced drainage and odor, and positive patient feedback. The discussion covers how the device fits into current debridement tools, safety and infection-control design choices, and the inventor’s vision for broader clinical adoption and training to help prevent amputations and advance limb preservation.

7 de jul de 202647 min